Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

486
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
486
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

769
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
769
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

509
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
509
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

875
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
875
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

873
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
873
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

41
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
41

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cystic Fibrosis and CFTR Modulators: The Impact on Bone Density, Muscle Mass and Strength in Children and Young Adolescents.

Children (Basel, Switzerland)·2025
Same author

Diabetic Peripheral Neuropathy, Diabetic Foot Ulcers and Selenium: A mini Review.

The international journal of lower extremity wounds·2025
Same author

Sarcopenia and Pleural Mesothelioma: The Current Knowledge.

Muscles (Basel, Switzerland)·2025
Same author

Sarcopenia and Pleural Effusions: Exploring a Potential Link.

Muscles (Basel, Switzerland)·2025
Same author

Sarcopenia As a Predictor of Survival and Complications of Patients With Cirrhosis After Liver Transplantation: A Systematic Review and Meta-Analysis.

Clinical transplantation·2025
Same author

B-Blockers in Liver Cirrhosis: A Wonder Drug for Every Stage of Portal Hypertension? A Narrative Review.

Biomedicines·2024
Same journal

Intra-Rater, Inter-Rater, and Test-Retest Reliability of a Laser- and Inclinometer-Based Hip Joint Position Sense Test in Healthy Adults: A Two-Phase Study with Preliminary Reference Values.

Muscles (Basel, Switzerland)·2026
Same journal

Nicotinamide Riboside Supplementation Protects Against Heat-Induced Skeletal Muscle Injury in Female Mice.

Muscles (Basel, Switzerland)·2026
Same journal

The Multi-System Roles of Dp71 Dystrophin Isoforms in Duchenne Muscular Dystrophy.

Muscles (Basel, Switzerland)·2026
Same journal

Correlation Between Hemoglobin Levels with Muscle Function and the Risk of Sarcopenia in Patients with Cancer of the Digestive System: A Cross-Sectional Study.

Muscles (Basel, Switzerland)·2026
Same journal

Structural and Functional Principles in Quadriceps Reconstruction.

Muscles (Basel, Switzerland)·2026
Same journal

Automated L3 Skeletal Muscle Segmentation for the Evaluation of Sarcopenia: Development and Independent Validation of an Ensemble-Based 2D nnU-Net Pipeline in a Complex Liver Disease Cohort.

Muscles (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Sep 12, 2025

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

510

Loop Diuretics and Sarcopenia: A Potential Association.

Nikolaos D Karakousis1, Petros N Georgakopoulos2

  • 1Independent Researcher, Vrilissia 15235, Greece.

Muscles (Basel, Switzerland)
|August 4, 2025
PubMed
Summary
This summary is machine-generated.

Loop diuretics (LDs) may increase sarcopenia risk in patients with chronic kidney disease (CKD) and heart failure (HF). This review suggests a potential link between LD use and muscle wasting, warranting further investigation.

Keywords:
chronic kidney diseaseheart failureliver cirrhosisloop diureticssarcopenia

More Related Videos

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
13:35

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Published on: March 21, 2021

10.7K
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

12.7K

Related Experiment Videos

Last Updated: Sep 12, 2025

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

510
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
13:35

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Published on: March 21, 2021

10.7K
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

12.7K

Area of Science:

  • Gerontology
  • Pharmacology
  • Nephrology

Background:

  • Loop diuretics (LDs) are commonly prescribed for heart failure (HF), liver cirrhosis, and chronic kidney disease (CKD).
  • Sarcopenia, characterized by muscle mass and strength loss, leads to adverse outcomes like frailty, falls, and increased mortality.

Purpose of the Study:

  • To investigate the potential association between loop diuretic (LD) use and the development of sarcopenia.
  • To synthesize current evidence on the relationship between LDs and muscle wasting across different patient populations.

Main Methods:

  • A non-systematic review of existing literature was conducted.
  • The review focused on studies examining LD use in conjunction with sarcopenia or related muscle health indicators.

Main Results:

  • Loop diuretic use was significantly associated with an increased risk of sarcopenia in non-dialysis-dependent CKD (NDD-CKD) patients.
  • Patients with HF on LDs exhibited smaller limb circumferences, suggesting muscle wasting.
  • Anorexic patients on diuretics and those with liver cirrhosis showed higher sarcopenia prevalence, with inverse correlation between LD dosage and muscle area in cirrhotic subjects.

Conclusions:

  • Evidence suggests a potential link between loop diuretic use and sarcopenia.
  • Further research is necessary to confirm the interplay between LDs and sarcopenia and its clinical implications.